These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8228082

  • 1. Experience with Eudragit-S-coated mesalamine (Asacol) in inflammatory bowel disease. An open study.
    Faber SM, Korelitz BI.
    J Clin Gastroenterol; 1993 Oct; 17(3):213-8. PubMed ID: 8228082
    [Abstract] [Full Text] [Related]

  • 2. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM, Duncan A, Russell RI.
    Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
    [Abstract] [Full Text] [Related]

  • 3. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine.
    Donald IP, Wilkinson SP.
    Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480
    [Abstract] [Full Text] [Related]

  • 4. Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
    Martin F.
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):57S-63S. PubMed ID: 2891469
    [Abstract] [Full Text] [Related]

  • 5. Experience with Eudragit-S coated mesalamine (Asacol) in inflammatory bowel disease: adverse events.
    Nichols TW.
    J Clin Gastroenterol; 1994 Mar; 18(2):181. PubMed ID: 8189029
    [No Abstract] [Full Text] [Related]

  • 6. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR, Mays DA.
    Ann Pharmacother; 1997 Mar; 31(7-8):907-13. PubMed ID: 9220055
    [Abstract] [Full Text] [Related]

  • 7. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW, Gales BJ.
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [Abstract] [Full Text] [Related]

  • 8. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
    Small RE, Schraa CC.
    Pharmacotherapy; 1994 Jun; 14(4):385-98. PubMed ID: 7937276
    [Abstract] [Full Text] [Related]

  • 9. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group.
    Ann Intern Med; 1996 Jan 15; 124(2):204-11. PubMed ID: 8533995
    [Abstract] [Full Text] [Related]

  • 10. Mesalazine in childhood inflammatory bowel disease.
    Barden L, Lipson A, Pert P, Walker-Smith JA.
    Aliment Pharmacol Ther; 1989 Dec 15; 3(6):597-603. PubMed ID: 2577501
    [Abstract] [Full Text] [Related]

  • 11. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
    Dew MJ, Hughes P, Harries AD, Williams G, Evans BK, Rhodes J.
    Br Med J (Clin Res Ed); 1982 Oct 09; 285(6347):1012. PubMed ID: 6127137
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
    Rachmilewitz D.
    BMJ; 1989 Jan 14; 298(6666):82-6. PubMed ID: 2563951
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study.
    Sninsky CA, Cort DH, Shanahan F, Powers BJ, Sessions JT, Pruitt RE, Jacobs WH, Lo SK, Targan SR, Cerda JJ.
    Ann Intern Med; 1991 Sep 01; 115(5):350-5. PubMed ID: 1863024
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis.
    Tremaine WJ, Schroeder KW, Harrison JM, Zinsmeister AR.
    J Clin Gastroenterol; 1994 Dec 01; 19(4):278-82. PubMed ID: 7876505
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.